Low-rank network signatures in the triple network separate schizophrenia and major depressive disorder.

Journal: NeuroImage. Clinical
Published Date:

Abstract

Brain imaging studies have revealed that functional and structural brain connectivity in the so-called triple network (i.e., default mode network (DMN), salience network (SN) and central executive network (CEN)) are consistently altered in schizophrenia. However, similar changes have also been found in patients with major depressive disorder, prompting the question of specific triple network signatures for the two disorders. In this study, we proposed Supervised Convex Nonnegative Matrix Factorization (SCNMF) to extract distributed multi-modal brain patterns. These patterns distinguish schizophrenia and major depressive disorder in a latent low-dimensional space of the triple brain network. Specifically, 21 patients of schizophrenia and 25 patients of major depressive disorder were assessed by T1-weighted, diffusion-weighted, and resting-state functional MRIs. Individual structural and functional connectivity networks, based on pre-defined regions of the triple network were constructed, respectively. Afterwards, SCNMF was employed to extract the discriminative patterns. Experiments indicate that SCNMF allows extracting the low-rank discriminative patterns between the two disorders, achieving a classification accuracy of 82.6% based on the extracted functional and structural abnormalities with support vector machine. Experimental results show the specific brain patterns for schizophrenia and major depressive disorder that are multi-modal, complex, and distributed in the triple network. Parts of the prefrontal cortex including superior frontal gyri showed variation between patients with schizophrenia and major depression due to structural properties. In terms of functional properties, the middle cingulate cortex, inferior parietal lobule, and cingulate cortex were the most discriminative regions.

Authors

  • Wei Han
    Department of Pharmacology, The Key Laboratory of Neural and Vascular Biology, The Key Laboratory of New Drug Pharmacology and Toxicology, Ministry of Education, Collaborative Innovation Center of Hebei Province for Mechanism, Diagnosis and Treatment of Neuropsychiatric Diseases, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Christian Sorg
    Department of Neuroradiology, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany; Department of Psychiatry, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany; TUM-Neuroimaging Center of Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
  • Changgang Zheng
    Data Mining Lab, University of Electronic Science and Technology of China, 611731 Chengdu, China.
  • Qinli Yang
    Data Mining Lab, University of Electronic Science and Technology of China, 611731 Chengdu, China.
  • Xiaosong Zhang
    Data Mining Lab, University of Electronic Science and Technology of China, 611731 Chengdu, China; School of Computer Science and Engineering, University of Electronic Science and Technology of China, 611731 Chengdu, China.
  • Arvid Ternblom
    Data Mining Lab, University of Electronic Science and Technology of China, 611731 Chengdu, China; School of Computer Science and Engineering, University of Electronic Science and Technology of China, 611731 Chengdu, China.
  • Cobbinah Bernard Mawuli
    Data Mining Lab, University of Electronic Science and Technology of China, 611731 Chengdu, China; School of Computer Science and Engineering, University of Electronic Science and Technology of China, 611731 Chengdu, China.
  • Lianli Gao
    School of Computer Science and Engineering, University of Electronic Science and Technology of China, 611731 Chengdu, China.
  • Cheng Luo
    Department of Cardiology, Liuzhou Workers' Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
  • DeZhong Yao
    The Key Laboratory for Neuro Information of Ministry of Education, Center for Information in Bio Medicine, High-Field Magnetic Resonance Brain Imaging Key Laboratory of Sichuan Province, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
  • Tao Li
    Department of Emergency Medicine, Jining No.1 People's Hospital, Jining, China.
  • Sugai Liang
    Hangzhou Seventh People's Hospital, Affiliated Mental Health Center, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Junming Shao
    The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China.